Biolinerx Ltd (BLRX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Biolinerx Ltd   (BLRX)

Biolinerx Ltd

Officers & Directors


Philip A. Serlin, CPA, MBA, age 65, has served as Chief Executive Officer since October 2016. He was previously Chief Financial and Operating Officer of BioLineRx from May 2009 to October 2016 and held senior financial roles at Kayote Networks Inc., Tescom Software Systems Testing Ltd., Chiaro Networks Ltd., Deloitte, and the SEC. Mali Zeevi, CPA, age 50, has been Chief Financial Officer since October 2016. She was formerly Senior Director of Finance and Reporting at BioLineRx and held finance positions at Tescom Software Systems Testing Ltd. and Kesselman & Kesselman. Ella Sorani, Ph.D., age 58, has been Chief Development Officer since January 2021. She previously served as Vice President of Research and Development at BioLineRx and held management roles at Teva Pharmaceutical Industries Ltd. Aharon Schwartz, Ph.D., age 83, has been Chairman of the Board of Directors since 2004. He was formerly Vice President at Teva Innovative Ventures, is currently a board member of Protalix Ltd., and works as an independent consultant. Rami Dar, MBA, age 69, has been a member of the board of directors since July 2022. He serves on the Audit, Compensation, and Investment Monitoring Committees and has held board positions at BetterSeeds Ltd., Nordia Springs, and Novolog Ltd.

Biolinerx Ltd currently has 24 employees.






BLRX Management Effectiveness BLRX Revenue per Employee BLRX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.